Literature DB >> 18563575

Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.

Namita B Prabhu1, Ajit S Marathe, SatishKumar Jain, Pirthi Pal Singh, Kiran Sawant, Leena Rao, Purnima D Amin.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18563575      PMCID： PMC2977020          DOI： 10.1208/s12249-008-9110-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  13 in total

1.  Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties.

Authors:  M S Bloomfield; W C Butler
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

2.  Ion-exchange resins: carrying drug delivery forward.

Authors:  V Anand; R Kandarapu; S Garg
Journal:  Drug Discov Today       Date:  2001-09-01       Impact factor: 7.851

3.  Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.

Authors:  Maria Vertzoni; Jennifer Dressman; James Butler; John Hempenstall; Christos Reppas
Journal:  Eur J Pharm Biopharm       Date:  2005-08       Impact factor: 5.571

4.  In vitro-in vivo correlation and comparative bioavailablity of vincamine in prolonged-release preparations.

Authors:  L H Emara; B S el-Menshawi; M Y Estefan
Journal:  Drug Dev Ind Pharm       Date:  2000-03       Impact factor: 3.225

5.  Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.

Authors:  N Ozdemir; S Ordu; Y Ozkan
Journal:  Drug Dev Ind Pharm       Date:  2000-08       Impact factor: 3.225

6.  Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans.

Authors:  L Bønløkke; L Hovgaard; H G Kristensen; L Knutson; H Lennernäs
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

7.  Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.

Authors:  Ian J Hardy; Anne Windberg-Baarup; Claudia Neri; Paul V Byway; Steven W Booth; Shaun Fitzpatrick
Journal:  Int J Pharm       Date:  2007-01-20       Impact factor: 5.875

8.  In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis.

Authors:  Nikoletta Fotaki; Mira Symillides; Christos Reppas
Journal:  Eur J Pharm Sci       Date:  2005-01       Impact factor: 4.384

9.  In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery.

Authors:  E Mehuys; C Vervaet; I Gielen; H Van Bree; J P Remon
Journal:  J Control Release       Date:  2004-04-28       Impact factor: 9.776

10.  Effect of ion exchange resins on the drug release from matrix tablets.

Authors:  M Sriwongjanya; R Bodmeier
Journal:  Eur J Pharm Biopharm       Date:  1998-11       Impact factor: 5.571
View more
  3 in total

1.  Bio-Hybrid Hydrogels Incorporated into a System of Salicylic Acid-pH/Thermosensitive Nanocarriers Intended for Cutaneous Wound-Healing Processes.

Authors:  Katarzyna Bialik-Wąs; Małgorzata Miastkowska; Paulina Sapuła; Klaudia Pluta; Dagmara Malina; Jarosław Chwastowski; Mateusz Barczewski
Journal:  Pharmaceutics       Date:  2022-04-01       Impact factor: 6.525

2.  Comparative Study of Antibacterial Effects of Titanium Dioxide Nanoparticles Alone and in Combination with Antibiotics on MDR Pseudomonas aeruginosa Strains.

Authors:  Fatma Y Ahmed; Usama Farghaly Aly; Rehab M Abd El-Baky; Nancy G F M Waly
Journal:  Int J Nanomedicine       Date:  2020-05-14

3.  The load and release characteristics on a strong cationic ion-exchange fiber: kinetics, thermodynamics, and influences.

Authors:  Jing Yuan; Yanan Gao; Xinyu Wang; Hongzhuo Liu; Xin Che; Lu Xu; Yang Yang; Qifang Wang; Yan Wang; Sanming Li
Journal:  Drug Des Devel Ther       Date:  2014-07-16       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.